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Abstract 
Many genes determining cell identity are regulated by clusters of mediator-bound 
enhancer elements collectively referred to as super-enhancers. These have been 
proposed to manifest higher-order properties important in development and disease. 
Here, we report a comprehensive functional dissection of one of the strongest 
putative super-enhancers in erythroid cells. By generating a series of mouse models, 
deleting each of the five regulatory elements of the α-globin super-enhancer singly 
and in informative combinations, we demonstrate that each constituent enhancer 
appears to act independently and in an additive fashion with respect to hematologic 
phenotype, gene expression, chromatin structure and chromosome conformation, 
without clear evidence of synergistic or higher-order effects. Our study highlights the 
importance of functional genetic analyses for the identification of new concepts in 
transcriptional regulation.   
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Recent reports describe a new class of regulatory elements called super-
enhancers1,2,3. These are defined as enhancer-like elements, bound by master 
regulators, particularly the Mediator complex, and bearing active chromatin marks 
(e.g. H3K4me1 and H3K27ac). Super enhancers typically comprise a cluster of 
regulatory elements, spanning up to 12.5 kb, and are frequently flanked by CTCF 
binding sites, suggesting that their activity may be constrained by boundary 
elements4. Although originally identified in embryonic stem cells, super enhancers 
have been described in many cell types5,6,7. Together these studies propose that a 
relatively small set of super enhancers act as key switches to determine cell fate. 
However, it is unclear whether super enhancers genuinely represent a new 
paradigm, describing a functional unit that is more than the sum of its parts, or 
whether they are simply an assembly of conventional enhancers of varying 
strengths8. Therefore, it is important to determine whether there are emergent 
functional properties uniquely associated with super enhancers.  
Here, using an unbiased approach1, we identified all super enhancers in erythroid 
cells and found that the two clusters of regulatory elements controlling expression of 
the α- and β-globin genes are classified as super enhancers in this cell type. The 
study of mammalian enhancers is hampered by the observation that these elements 
are defined by criteria only partially or indirectly related to their role in vivo9,10. We 
therefore used homologous recombination to make seven mouse models in which 
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each constituent of the proposed α-globin super enhancer is deleted, singly and in 
informative pairs, to dissect the its function. 
 
We find that no single element is critical for globin gene expression and, although 
each element scores as an erythroid enhancer based on conventional chromatin 
signatures and enhancer assays, only two of the five elements behave as strong 
enhancers in vivo during embryonic, fetal, and adult erythropoiesis. These two strong 
enhancers fall into a subgroup of individual erythroid enhancers which are bound by 
the greatest amount of Mediator and the highest numbers of erythroid master 
regulators. Such regions have been referred to as “hotspots”6. Importantly, we find 
no evidence of emergent functional properties from the extended enhancer cluster; 
each element appears to contribute to gene expression as individual enhancers in an 
additive rather than synergistic manner. Thus the super enhancer associated with 
the globin genes may be more simply described as a group of conventional 
enhancers including at least one strong enhancer, rather than as a new discrete 
entity with properties greater than the sum of its parts.   
Results  
Five α-globin regulatory elements form an erythroid super enhancer  
Primary mouse erythroid cells were analysed to identify and characterize super 
enhancers in this cell type. All cis-regulatory elements in primary mouse erythroid 
cells were initially identified by characterizing DNase I hypersensitive sites (DHS)11. 
In total, 15,849 DHS were identified in purified erythroid (Ter119+) cells from 
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C57BL/6 mice. After characterizing chromatin signatures at all DHS (Fig. 1A, 
Supplementary Fig. 1a and b), we excluded elements with low levels of H3K4me1 
and H3K4me3 (<10 reads/million). A significant proportion of DHS correspond to 
CTCF binding sites (Supplementary Fig. 1a and b). In the remaining 10,542 DHS, 
enhancers were distinguished from promoters by their ratio of H3K4me3 to 
H3K4me1 (Fig. 1B, Supplementary Fig. 1a). Finally, this enhancer group was further 
refined by removing 29 DHS located within 250bp of annotated transcription start 
sites. The resulting set of 1963 putative enhancers has the chromatin signature 
previously shown to be enriched at enhancers (Fig. 1a and 1b)12,13,14.  
To identify erythroid super enhancers, we used the ROSE algorithm3, ‘stitching’ 
together individual enhancers within 12.5 kb of each other to define a single entity 
spanning a contiguous genomic region. The stitched enhancers and the remaining 
individual enhancers (those without a neighbouring enhancer within 12.5 kb) were 
then ranked by the level of Med1 signal within the extended genomic region. A small 
number (95) of these enhancer regions (<7%) bound very high levels of Med1. By 
definition1,3, elements with a Med1-value above a cut-off where the slope of the 
distribution plot of Med1 ChIP-seq intensity is 1 were designated super enhancers 
(Fig. 1c). The remaining enhancers were considered to be regular enhancers. As in 
other cell types1, and by definition, Med1 levels were most informative in 
distinguishing between super enhancers and regular enhancers (Supplementary fig. 
1c).   
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As in previous studies1,15, super enhancers often spanned large genomic regions, 
and contained multiple constituent enhancer elements (Fig. 1d). In erythroid cells, 
their median size is an order of magnitude larger than that of regular erythroid 
enhancers (5650 bp versus 866 bp). As well as the defining enrichment of Med1 
(Fig. 1e), we also found significant enrichment of key erythroid-specific transcription 
factors (Supplementary Fig.1d and e) and their binding motifs (Supplementary Fig. 
1f). The previously reported α- and β-globin gene regulatory regions were the two 
highest scoring super enhancers in erythroid cells using Mediator-binding as the 
defining parameter (Fig. 1c and Supplementary Table 1). This was also true using 
any of the other reported diagnostic parameters (Supplementary Table 1). Like other 
super enhancers15, the globin super enhancer lies close to the cell-specific gene it 
regulates (Fig. 1f). .  
 
The mouse α-globin super enhancer identified using these methods spans 24 kb and 
contains five enhancer-like elements, four of which lie in the introns of an adjacent, 
widely-expressed gene (Nprl3) (Fig. 1f). The entire α-globin cluster is flanked by two 
pairs of CTCF binding sites (Fig. 1f), a common observation for super enhancers15.  
 
Given that the α-globin super enhancer typifies this newly proposed class of element, 
we used it as a model to examine in detail the structure and function of super 
enhancers.    
Transcription factor binding varies between super enhancer components 
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Each of the constituents of the α-globin super enhancer is bound by different 
combinations of erythroid transcription factors and varying levels of Med1 (Fig. 1f). 
Analysis of the composition of regular enhancers and super enhancers showed that, 
as expected, super enhancers are enriched for composite enhancers (Fig. 1d); the 
greater the number of constituent elements, the more likely the region will be 
classified as a super enhancer (Supplementary Fig. 1g). An increase in the number 
of constituent elements correlated to higher levels of Med1 (Fig. 2a). When individual 
enhancers were ranked for Med1 occupancy without stitching, Med1 binding varied 
considerably between the five constituent enhancers of the α-globin super enhancer 
(Fig. 2b). Using the same methodology as described above to determine a cut-off, 
the four evolutionarily conserved α-globin regulatory elements (R1-4)16 still fell into 
the class of highly Med1 bound regions when analysed as single elements, whereas 
Rm (a species-specific cis-element) fell below the proposed criterion (Fig. 2b).   
We applied an unbiased clustering approach to further characterize the individual 
components of all erythroid super enhancers. A Partitioning Around Medoids (PAM) 
algorithm was used to group similar regulatory elements based on the binding levels 
of the four master erythroid transcription factors Nf-e2, Gata1, Scl and Klf1, and the 
ubiquitously expressed factor CTCF. In addition to groups of elements that were 
bound by none (cluster 0) or all (cluster 1) of the transcription factors, 16 further 
clusters each binding distinct combinations of transcription factors were identified. 
PAM clusters were ranked for average Med1 signal per cluster and visualized in a 
heatmap (Fig. 2c). Motif analysis supported the clustering results, confirming 
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enrichment of binding motifs that matched the different combinations of the four 
investigated transcription factors found in each cluster by ChIP-seq (Supplementary 
Table 2). Despite not showing enrichment for transcription factor binding by ChIP-
seq, DNase I hypersensitive elements in cluster 0 (containing approximately 25% of 
all enhancers) were enriched for Gata1, Gata-Scl and Klf1 binding motifs indicating 
that low levels of these erythroid transcription factors may bind to these elements.   
Interestingly, the ranking of clusters for Med1 binding revealed higher levels of Med1 
at enhancers containing a larger number of transcription factor binding sites (Fig. 2c 
and 2d). These elements were also more likely to be incorporated in super 
enhancers (Fig. 2e). Although this was the case for elements contained within both 
regular enhancers and super enhancers, constituents of the latter had higher levels 
of Med1 binding than enhancer regions outside super enhancers.  
 
We investigated whether any of the clusters were overrepresented in super 
enhancers (Fig. 2d). Cluster 2, containing enhancers binding all four erythroid 
transcription factors, was significantly enriched, being present in over 30% of 
erythroid super enhancers. Consistent with the recent identification of transcription 
factor “hotspots” as key components of adipogenic super enhancers 6, enhancer 
elements bound by a high number of transcription factors are enriched in erythroid 
super enhancers.   
We next applied this analysis to the constituent elements of the α-globin super 
enhancer  (Fig. 2f). Of its five constituent elements, R1 and R2 were both present in 
 9 
cluster 2, and had the highest levels of Med1 (Fig. 2c). The elements R3 and R4 
were found in cluster 4, binding lower levels of Med1 and only three of the 
transcription factors (Gata1, Scl and Klf1). Finally, the mouse-specific regulatory 
element, Rm, to which only two of the key transcription factors were bound (Nf-e2 
and Gata1), was part of PAM cluster 6. Thus, the constituents of the α-globin super 
enhancer show considerable variation in Med1 and transcription factor binding, 
raising the possibility that they may vary in their contribution to α-globin gene 
regulation.   
Enhancer assays do not reliably describe super enhancer elements  
Mammalian enhancers are defined as distal genetic elements that positively regulate 
expression in an orientation-independent manner in heterologous gain of function 
expression experiments. Using a transient, non-integrated, in-vivo Citrine reporter 
assay in developing chicken embryos, we tested the enhancer activity of the five 
elements.  
 
Enhancer activity was initially detected in Hamilton-Hamburger stage 9 embryos in 
the developing blood islands, where it persisted throughout development (Fig. 3a), 
consistent with the expression of globin here. Later during development, enhancer 
activity was also detected in the circulating blood (Fig. 3a and Supplementary Video 
1), and was most prominent in the heart and head where the greatest density of red 
blood cells is found (Fig. 3a, panels 6-10).  Expression was most prominent for the 
R1 enhancer, while the activity of the R2 enhancer is detected more broadly across 
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the head and trunk.  R3 and R4 had comparable patterns of expression to R2. Rm 
had the lowest level of late activity in regions other than blood islands, with only low 
levels of Citrine reporter expression detected in the head.  No activity was observed 
with the negative control (Supplementary Fig. 2a). Consistent with our findings in the 
PAM analysis the effects of these non-integrated constructs in transient assays 
reflect the numbers and types of transcription factor binding sites present in each 
element.  
Each element was also tested using the well-established mouse transgenic 
system17,18, where a vector containing a candidate enhancer, a minimal promoter 
and the LacZ gene is stably integrated into chromatin at random positions in the 
mouse genome. Examination of whole embryos at E12.5 following LacZ staining 
suggested that only R2 exhibited positive enhancer activity in hematopoietic cells at 
this time point, with 5 of 7 LacZ-stained embryos exhibiting an expression pattern 
consistent with erythroid enhancer activity (Fig. 3b and Supplementary Table 3). We 
prepared tissue sections from three LacZ positive mice for each enhancer construct 
tested; these confirmed strong enhancer activity for R2 and also demonstrated 
weaker activity for R1, while no activity was detected for the remaining three 
elements (R3, R4 and Rm) (Fig. 3b). Thus, despite their chromatin signatures, these 
three elements would not be classified as enhancers by this standard assay; only 
those two elements with the most extensive transcription factor binding profile as 
determined by PAM analysis scored positively in the assay. 
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No single element is critical for globin gene expression  
To determine the contribution of each enhancer to α-globin transcription within the 
context of the super enhancer (Fig. 4a) we generated knockout mouse models for 
each constituent element. Knockouts were generated by homologous recombination 
for all five components of the α-globin super enhancer (plus two informative 
combinations of knockouts, see below) Two of these deletions (R2-/- and R3-/-) have 
been previously described19,14.   
We analysed the viability of mice homozygous for each individual deletion. 
(Supplementary Table 3). In all cases, offspring were seen in expected Mendelian 
ratios, and homozygotes survived to adulthood and bred normally.  
To assess whether the loss of individual enhancer elements influenced the 
hematologic phenotype, blood counts and smears were examined. No single 
knockout reduced the hemoglobin concentration in adult mice below the normal 
range (Fig. 4b) nor did they result in a significant reduction in either mean red cell 
volume or mean red cell hemoglobin beyond the normal range (Supplementary Fig. 
3), although we noted a non-significant trend towards a lower MCV and MCH in the 
R2-/- mice (as previously reported19). All hematologic data are summarised in 
Supplementary Table 4.   
We noticed an increased variation in staining (polychromasia) in R1-/- and R2-/- mice 
(Fig. 4d), suggesting that stress erythropoiesis is required to maintain normal 
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hematologic parameters in these models. We evaluated this using the reticulocyte 
count and noted significantly increased counts in R1-/- and R2-/- mice (Fig. 4c and d). 
suggesting these mice maintain normal red cell parameters only through stressed 
erythropoiesis. Knockouts of R3, R4 and Rm appear to have little, if any, effect on α-
globin expression or erythropoiesis.   
Quantification of the impact of each enhancer on α-globin transcription was initially 
performed using an RNA protection assay and qPCR. These assays showed no 
consistent evidence of altered α-globin RNA expression in homozygotes for 
knockouts of individual sites, although we noted a trend towards reduced α-globin 
RNA expression in R2-/- (as previously described19). However, these techniques 
evaluate accumulated RNA and, at best, identify fold changes in expression, 
precluding the identification of fractional changes. We therefore developed a 
modified method20 to quantify total and metabolically-labeled nascent RNA in 
populations of synchronously maturing primary erythroid cells from each mouse 
model. Fetal liver cells were isolated at E12.5 to permit assessment of definitive 
erythropoiesis in homozygotes of all models, including the embryonically lethal 
R1/R2-/- model. RNA from equivalent populations of synchronously maturing 
erythroid cells (Supplementary Fig. 4a) was quantified using Nanostring21, enabling 
simultaneous measurement of expression of all globin genes plus five control genes 
expressed throughout erythroid maturation. The approach was validated using 
nascent RNA-seq (Fig. 5d and supplementary Fig. 4b).    
 13 
Fig. 5a and 5b demonstrate that individual elements of the super enhancer are not 
functionally equivalent. Deletions of R1 and R2 have a significant and reproducible 
impact on the synthesis of α-globin RNA. Deletion of R4 has a minor impact. 
Deletions of R3 and Rm, however, have no discernible impact on α-globin RNA 
synthesis (Fig. 5b).   
While the impact of homozygosity for the R1 and R2 deletions on the α:β globin 
mRNA ratio is significant, there appears to be compensation for this imbalance in the 
peripheral blood. The hemolysis and ineffective erythropoiesis induced by the 
skewed α:β ratio result in an increased production of erythroid cells (Fig. 4c and 4d); 
those cells with the greatest imbalance in globin synthesis are likely to be destroyed 
prior to leaving the bone marrow, leaving little change in the peripheral red blood 
cells or hematologic indices.  
 
Thus, the regulatory effect of the α-globin super enhancer depends mainly on two 
elements, R1 and R2; the other three elements contribute very little, if at all, to the 
activity of the super enhancer in vivo. Importantly, it can be seen that the super 
enhancer does not act as a multi-component structure; removal of any single 
element cannot abolish its function.  
The enhancer elements act in an additive manner  
To determine if the apparently inactive enhancer-like elements play a compensatory 
role when a major element is removed, or if the removal of two elements rather than 
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one might collapse the super enhancer structure, we generated mice in which both 
an active (R2) and inactive enhancer-like element (we arbitrarily chose R3) were 
deleted in cis. We found that homozygotes for this double deletion were born in the 
normal Mendelian ratios and were viable into adulthood. Adults are indistinguishable 
from R2-/- mice both hematologically (Fig. 4b) and transcriptionally (Fig. 5).   
Next we made mice in which both active elements R1 and R2 are removed in cis. 
Heterozygotes for the R1/R2 knockout were viable and were able to breed normally. 
However cross breeding of heterozygotes showed significantly reduced litter sizes 
and no homozygotes at term. The sacrifice of pregnant females following timed 
matings showed that R1/R2-/- mice were smaller and paler than WT or heterozygote 
littermates, with nuchal edema (arrowed, Figure 5c; Supplementary Table 4). These 
mice die in utero at ~E14.5   
The embryonic lethality of R1/R2-/- mice means that hematologic indices could be 
assessed only in heterozygotes. These have reduced MCH and MCV and raised 
reticulocyte counts typical of thalassemia (Fig. 4). Analysis of α:β globin RNA ratios 
showed that R1/R2-/- fetal liver cells produced very little α-globin RNA (Fig. 5). 
Further, within the limits of the experimental method, the contributions of R1 and R2 
to transcription appear to be additive rather than clearly synergistic. The remaining 
<10% of normal α-globin RNA levels, is likely to be transcribed under the influence of 
the intact cis-elements. Our data suggest that R4 may contribute to this.  
The chromatin environment does not depend on the intact super enhancer 
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Each cis element in the α-globin regulatory domain is associated with a nuclease-
sensitive site, demonstrated by DNase I sensitivity and ATAC-seq11. To determine if 
the hypersensitive sites within the α−globin super enhancer are interdependent, we 
analysed the ATAC-Seq profile in fetal liver culture erythroid cells from homozygotes 
for each regulatory element knockout (Fig. 6a). We show that the presence of no 
individual hypersensitive site critically depends on any other: they appear to form 
independently. Even in the most phenotypically severe R1/R2-/- model, 
hypersensitive sites at R3, R4 and Rm still form. 
 
In the absence of R1 and R2, the peaks of hypersensitivity at the α-globin promoters 
are reduced when compared to wild type (Fig. 6a, Supplementary Fig. 5a). However, 
on genome-wide analysis, of R1/R2-/- cells, we found no changes to global 
hypersensitive site formation beyond those commensurate with inter-individual 
variation (Supplementary Fig. 5b).  
 
Using Next Generation Capture-C22, we have previously shown that a region of 
approximately 70 kb, including the α-globin genes and the super enhancer, are 
contained within a tissue-specific “compartment” in which the individual regulatory 
elements interact with each other, the promoters of the globin genes, and the 
surrounding chromatin. Assessing this in fetal liver culture erythroid cells from the 
knockout models demonstrates very little change in the compartment between the 
wild type and any single knockout (Fig. 6b). The intact super enhancer is therefore 
not required for the formation or maintenance of the chromatin compartment. 
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Although the interactions between the α-globin promoters and the regions around 
the R1 and R2 enhancers are markedly reduced in R1/R2-/- cells, they remain above 
the baseline levels found in ES cells (Supplementary Fig. 6. The interaction between 
the promoters and the CTCF site located between the enhancers is also reduced, 
though still present in R1/R2-/-, as is the interaction between the promoters and the 
weaker enhancer R4. In R2/R3-/-,cells, the promoters’ interactions with R1 are 
diminished but those with Rm and R4 are virtually unchanged compared to wild type. 
These data suggest that distal strong enhancers R1 and R2 potentiate the 
interactions between the elements (R3, Rm and R4) and the α-globin promoters.  
 
When we extended the assessment of chromosomal conformation genome-wide 
using next-generation Capture-C, the only statistically significant changes seen in 
even the most phenotypically severe double knockouts were those at the α-globin 
promoters (Supplementary Fig. 7).  
Discussion 
Based on genome-wide studies pioneered by the ENCODE project 
(www.encodeproject.org), a surprisingly large number of regulatory elements have 
been identified (2.9 million DHS across various human cell types23 or ~300,000 cis-
regulatory elements in various murine tissues24). This equates to 15 -150 elements 
for every structural gene. Yet assays of their functional roles remain sub-optimal, 
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typically examining elements outside their natural chromosomal environment, which 
can give, as we describe, conflicting results.  
Further classification of regulatory elements has been driven by the observation that 
some elements bearing the signatures of enhancers cluster around particular genes 
in specific tissues. Such clusters of enhancers were first referred to as locus control 
regions25, then stretch enhancers26 and super-enhancers1. Clearly, it is important to 
distinguish between models which propose an emergent property from this grouping 
(and thus a new type of element, e.g. super enhancers), from a more simple 
clustering of regular enhancers.   
We have systematically addressed this at the mammalian α-globin locus. Here we 
have shown that the linked α-globin regulatory elements fulfil the criteria for being 
among the highest-ranking super enhancers in erythroid cells. Each component is 
marked by a DHS, binds key cell-specific transcription factors and the Mediator 
complex, is modified by H3K4me1 and H3K27ac, and produces eRNAs and 
lncRNAs14. Each element scores positively in a transient enhancer assay. Although 
we have not assessed possible changes in Med1 binding, activating chromatin 
marks, or eRNA production in the context of each enhancer knockout27, we have 
found that each element within the cluster appears to act independently rather than 
co-operatively, with removal of any one element having little or no effect on the 
function of the others. Similarly, removal of two elements does not appear to 
abrogate the formation of other enhancer elements showing that the cluster does not 
act as an interdependent holo-complex. Previous less extensive studies have also 
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shown that the individual regulatory elements of the β-globin LCR, which we show 
here also corresponds to an erythroid super enhancer, behave in a similar 
independent and additive manner28. While we cannot extrapolate from these findings 
to all super enhancers, previous principles of gene regulation first established for the 
globin genes have, without exception, been shown to be generally applicable.   
Importantly we have shown that although all components of the cluster would be 
classified as enhancers they are not functionally equivalent. Whereas R1 and R2 are 
strong enhancers in their natural chromosomal environment, R3, Rm and R4 are 
either very weak enhancers or are not enhancers at all, despite their chromatin 
marks. Of interest only R1 and R2 score positively in an enhancer assay in which the 
sequences are incorporated into chromatin. Further sub-classification of all erythroid 
enhancers shows that R1 and R2 are distinguished by binding the greatest number 
of cell-specific transcription factors and the greatest amount of Mediator, and they 
are also associated with the most extensively modified chromatin. These sites 
correspond to elements that others have referred to as “hotspots”. However, they 
could more simply be referred to as strong individual enhancers.   
From the data presented here and from others29, 30, it seems likely that multiple 
enhancers may provide robustness in gene expression. Removal of either strong 
enhancer (R1 or R2) at the α-globin locus produces stressed erythropoiesis to 
ensure normal hemoglobin production. Under conditions of environmental or 
physiological compromise it is possible that having two enhancers rather than one 
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would provide a selective advantage. Such enhancers have previously been referred 
to as “shadow enhancers”31.  
One puzzle emerging from this study is why enhancer-like elements which clearly 
score positively on indirect assays have no discernible function in their natural 
chromosomal environment. One possibility is that they do have a weak enhancer 
function which is not easily revealed by current physiological assays. Alternatively, 
they play a more significant role at different stages of development or may define the 
polarity of the enhancer: this has not been tested in this study.    
We would suggest, however, that these elements reflect evolutionary turnover in cis-
acting elements as seen in other studies32. It is unlikely that cis-acting elements 
emerge fully formed during evolution or that they disappear entirely when they lose 
function; the apparently functionless elements we identify could therefore represent 
evolving enhancers. Indeed, it has been proposed that transcription factor hotspots, 
such as R1 and R2, create a permissive chromatin environment for the emergence 
of new transcription factor binding regions6. 
 
Our data do not support the suggestion that super enhancers have a singular 
composite function, but rather that strong enhancers simply augment the interactions 
between their chromatin environment and cognate promoters. This generates a 
compartment of interaction between the chromatin surrounding the enhancer and the 
promoter, which results in an environment that might favor the evolution of other 
enhancers.  
 20 
  
Our study, together with previous work at the β-globin LCR, does not support further 
sub-classification of enhancers beyond the simple designation of strong to weak 
elements. These may be usefully ranked by the number of lineage-specific 
transcription factors that they bind, in turn reflected by the degree of binding of 
Mediator and by the associated activated chromatin modifications. When tested at 
the α-globin locus, clustering of enhancers in super enhancers does not appear to 
lead to any unexplained emergent properties. However, genetic dissection of other 
super-enhancers in other cell types is warranted to provide a more comprehensive 
understanding of super enhancer function. 
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Figure legends  
Figure 1.  The α-globin regulatory region typifies a super-enhancer in erythroid 
cells (a). Heatmap representation of DNase-seq and ChIP-seq signal +/-2kb around 
the DNase I peak call regions (15,849 peaks), sorted by the ratio of H3K4me1 to 
H3K4me3. In the side panes the annotated "putative enhancers" are marked blue, 
and "putative promoters" marked red. (b). Annotation of all DNaseI peak regions 
(black) as putative enhancers (blue) and putative promoters (red). Annotation 
category cut-offs are marked by cyan lines. Promoters and enhancers are identified 
as described. (c). All identified enhancers (n = 1,963) within 12.5kb were ‘stitched’ 
together, resulting in 1,268 regions that were ranked for Med1 ChIP-seq signal 
(input-subtracted total reads). In total, 95 stitched enhancer regions were classified 
as super-enhancers, including the α- and β-globin regulatory regions. (d). The 
number of constituent enhancers present among the 1,173 stitched regular 
enhancers and the 95 stitched super-enhancers. Although super-enhancers are 
enriched for composite enhancers with a high number of constituents, both classes 
contain single and composite enhancer regions. (e). Med1 binding (input-subtracted 
reads per million per basepair) across stitched, regular (n = 1,173) and super-
enhancers (n = 95) and a region of 3kb up- and downstream. The median size of 
regular and super-enhancers is used to scale the region between start and end. (f). 
DNase-seq and ChIP-seq profiles for Med1, Gata1, Klf1, Nf-e2, Scl, and CTCF 
across the α-globin locus (mm9 in primary Ter119+ erythroid cells. The paired CTCF 
sites flanking the α-globin locus are highlighted in blue. (Coordinates, mm9: 
chr11:32,125,268–32,229,368.) 
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Figure 2.  Erythroid super-enhancer constituents vary in transcription factor 
binding and chromatin signature (a). Boxplot showing normalized Med1 ChIP-seq 
density (input-subtracted reads/basepair/million) to constituent enhancer regions as 
a function of the number of constituents present in the stitched enhancer region. 
(Box plot shows median and interquartile range; whiskers define 1.5 × IQR) The 
histogram displays the relative distribution of composite enhancers. (b). All identified 
enhancers (n = 1,963) were ranked for Med1 ChIP-seq signal (input-subtracted total 
reads), and 148 individual enhancers were classified as High-Med1 enhancers. The 
α-globin enhancers have been highlighted as red triangles. (c). PAM-clustering 
results for the "putative enhancers". Clusters 2–17 are ranked by mean Med1 signal 
(cluster 2 highest, cluster 17 lowest signal). Raw read counts, downscaled, input-
corrected, background-subtracted and normalized to Klf1 ChIP-seq data within the 
peak regions. Regions having >15 reads are shown in black. (d). The fraction of 
individual enhancers that are constituents of super-enhancers (as defined in Fig. 1C) 
in each cluster. Clusters are ranked by mean Med1 signal of individual enhancers 
within the cluster. The colour of the bars indicates the number of master erythroid 
transcription factors bound to the individual enhancers of the cluster. (e). Med1 
ChIP-seq signal (input-subtracted total reads) at individual enhancers and the 
fraction of individual enhancers that are constituents of super-enhancers as a 
function of the number of bound transcription factors. In total 570 enhancers are 
bound by one factor; 459 by two factors; 237 by three factors; and 129 by four 
factors.  
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Figure 3. Enhancer assays of individual elements  
(a) Reporter assays for activity of 5 α−globin enhancers during chick embryonic 
development. Panels A1-5: Activity of all five enhancers was detected in the 
developing blood islands, indicated by arrows, in the posterior part of the embryo, at 
Hamilton Hamburger stage 12 (HH12). Anterior is oriented to the top. Panels A6-10. 
HH14 reporter activity, driven by all enhancers, was also detected in circulating 
blood, most notably in the head and heart. Ubiquitous expression of Histone 2B-
tethered RFP was used as electroporation control. BI, blood islands; OFT, outflow 
tract; IFT, inflow tract; H, heart; HB, hindbrain. Scale bar represents 1 mm. Further 
details are given in Supplementary Table 3. 
(b) Functional analysis of enhancer activity in E12.5 mouse embryos. The upper 
panels (b1-5) show a representative LacZ stained embryo for each of the enhancer 
constructs indicated. Lower panels (b6-10) show a section through the heart (R1) or 
dorsal aorta (R2-4 and Rm), showing a population of hematopoietic cells. R1 shows 
a low level of activity in a subset of cells (arrowed), R2 shows robust activity in the 
majority of hematopoietic cells, but there is no detectable activity in these cells from 
R3, R4 or the Rm element. Scale bar represents 1 mm in panels 1–5 and 50µm in 
panels 6–10. Further details are given in Supplementary Table 3.   
Figure 4. Hematologic impact of single and double enhancer knockouts  
(a). Mouse α-globin locus (chromosome 11), illustrating the α-globin genes (Hba-a1 
and Hba-a2, blue highlight); the five α-globin enhancers (R1, R2, R3, Rm and R4, 
grey) and the regions deleted in each enhancer knockout models (green) in relation 
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to multispecies conserved regions (red). (b). Hemoglobin was measured in adult 
blood from mice homozygous for each individual enhancer knockout, and for 
homozygotes for the R2/R3-/- double deletion. None of the enhancer knockout 
models exhibits hemoglobin levels outside of the normal range (red shaded box). 
Hematologic parameters for the R1/R2-/- double knockout could not be analysed due 
to its embryonic lethality and hematologic data shown for this model are from adult 
heterozygotes only. (c). Total reticulocyte count for each model. A significantly 
elevated reticulocyte count is observed in the R1-/- and R2-/- knockout models. All 
other models fall within the normal range (red shaded box). (d). Blood films (top 
panel) and brilliant cresyl blue (BCB) stained blood (lower panel) from the blood of 
wild type (WT), R1-/- and R2-/- mice. Whilst the blood films from the three genotypes 
are essentially identical, increased reticulocytes can be observed in BCB films from 
the R1-/- and (to a lesser extent) R2-/- mice.  Data shown represent means and 
standard deviation. All data are from independent biological replicates, with numbers 
per group given in Supplementary Table 5. Statistical analysis was performed using 
a one-way ANOVA with Dunnett’s correction. No randomization was required for any 
mouse analysis.  
Figure 5.   α-globin transcription in single and double enhancer knockouts  
(a) NanoString quantification of the ratio between α- and β-globin transcripts in 
steady state RNA isolated from primary mouse fetal liver cells from homozygote 
mice at E12.5. Samples were taken 12 hours after exposure to high levels of Epo 
(intermediate erythroblasts). A variable but significant reduction in the α:β-transcript 
ratio is observed in the R1-/-, R3-/-, R4-/- and R2-/-/R3-/- knockouts.  A 90% reduction is 
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seen in the R1-/-/R2-/- double knockout. (b). NanoString quantification of the α:β-
globin transcript ratio in nascent RNA isolated from primary mouse fetal liver cells at 
the same stage as Figure 5a. Modest effects are observed in the R1-/-, R2-/- R4-/- and 
R2-/-/R3-/- models, with the greatest reduction in α:β-transcript ratio observed in the 
R1-/-/R2-/- double knockout. All data are from a minimum of 3 independent biological 
replicates, and are shown as mean with standard deviation. Statistical analysis is by 
one-way ANOVA with Dunnett’s correction (**** reflects p<0.0001). (c). Embryos 
from WT (++), heterozygote (+/-) and homozygotes (-/-) for the R1/R2 knockout 
taken at E14.5 Homozygotes are smaller and paler with hemorrhagic areas and 
evidence of nuchal edema (arrowed). (d). RNA sequencing of nascent RNA obtained 
from primary fetal liver cultures using metabolic labeling. Unspliced directional 
transcripts are shown across the α−globin cluster 
  
Figure 6. Analysis of chromatin structure. (a). Open chromatin landscape (ATAC-
seq) at the α-globin cluster in wild type, five individual single enhancer knockout and 
two double enhancer knockout mice. Formation of the elements in the cluster is not 
impaired by deletion of any individual enhancers, nor by the double deletions. The 
position of each individual element of the predicted α globin super-enhancer is 
named and highlighted by red dashed lines. (Coordinates, mm9: chr11:32,123,000–
32,209,000.) 
(b). Comparison of the interaction profiles from the Hba-a1&2 promoters in primary 
erythroid cells from WT mice, each of the single and double enhancer knockout 
models and ES cells (E14). NG Capture-C was performed using the Hba-a1&2 
promoters as a viewpoint (since the genes are virtually identical this represents a 
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composite interaction profile from both promoters).  The X-axis displays the number 
of unique interactions from the promoter fragments with each DpnII fragment 
genome-wide, normalised for total number of interactions. DpnII fragments 
overlapping the deleted regions removed for visual clarity.  The region displayed in 
panel a is indicated by a black dashed line below the interaction profiles. 
(Coordinates, mm9: chr11:32,032,001–32,332,000.)    
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Online Methods 
 
Analysis of cis-elements 
DNase I hypersensitive sites, ATAC accessibility and ChIP sequencing to 
characterize cis-acting elements were performed and analysed as previously 
described14, 33. For ChIP-seq analysis, all data were aligned using Bowtie (version 
1.0.0)34 to the NCBI37/MM9 build of the mouse genome. Alignments were performed 
with the following parameters: -m 2, -k 1,–best. Enhancers were identified from a 
peak call of C57BL/6 mouse DNaseI hypersensitive regions. 
 
 SeqMonk (http://www.bioinformatics.babraham.ac.uk/projects/seqmonk/) was used 
for an independent peak call of two technical replicates of biological duplicate 
experiments11. The ploidy regions, as well as peaks higher or equal in signal in 
sonication input were excluded. Each of the files was manually curated, to exclude 
remaining background peaks in MIG35. The peak calls were merged to yield a single 
high-confidence DNaseI hypersensitive regions file containing 15,849 peaks. To 
identify putative enhancer elements, and to avoid a bias towards a limited set of 
transcription factors, DNaseI hypersensitive peaks were classified based on the ratio 
between the coverage of H3K4me1 and H3K4me3 signal within each peak call 
region. H3K4me1 and H3K4me3 coverage was normalised to million mapped reads 
before determining the ratio (in house script: Quantbam.pl). A total of 5,307 peaks 
were annotated to be low in both markers, as both H3K4me1 and H3K4me3 marks 
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had <10 rpm coverage. The rest of the peaks were further divided into putative 
enhancers and promoters. Regions were annotated as enhancers if the ratio 
between H3K4me3:H3K4me1 was <1. Annotated enhancers that were within 250bp 
of refGene annotated transcription start sites were removed from the set. 
 
Super-enhancers were identified using the ROSE tool1. Briefly, individual enhancers 
within 12.5kb were stitched together to form a single, larger enhancer domain. 
Stitched enhancer domains were then ranked for input-normalized ChIP-seq 
occupancy of Med1. The x-axis point at which the tangent to a scaled graph with X 
and Y axes ranging from 0-1 had a slope of 1 was used as a cut-off, above which 
stitched enhancers were classified as super-enhancers. This same methodology was 
followed to analyse the erythroid enhancers for the occupancy of DNaseI, H3K4me1, 
H3K27ac and a combination of four erythroid transcription factors (Gata1, Scl, Klf1, 
Nf-e2). The signal for each of the factors was normalized to a maximum value of 1.0 
and visualized after sorting the enhancers for the relative signal. To identify 
individual high-Med1 enhancers we used the ROSE tool in a similar manner as 
described above, only specifying a stitching distance (option -s) of 0 and thereby 
preventing the stitching of individual enhancers elements before downstream 
analysis.  
 
Factor Enrichment Analysis  
For quantification of ChIP-seq signal we calculated the normalized read density after 
removal of PCR duplicates. Reads were extended by 200 bp and we calculated the 
number of reads per basepair (bp). The calculated read densities were then 
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normalized to the total number of million mapped reads to produce the reads per 
million mapped per basepair (rpm/bp). Finally, ChIP-seq rpm/bp values were 
normalized to input by subtraction. 
 
PAM-clustering 
PAM-clustering analysis was done with library "cluster" in R.36 Before clustering, the 
coverages of all TFs of interest and CTCF (and the sonication input) were counted, 
and down-sampled to the Klf1 read counts (the dataset with the lowest total number 
of mapped reads). The sonication input value was subtracted from the coverages, 
and 13 reads (approximate max height of Klf1 baseline read depth) was subtracted 
from all coverages. All regions which had at least 4 reads were set to have 4 reads 
as the coverage. This essentially led to close to binary clustering, as most regions 
now had either 0 or 4 reads. After that the regions were subjected to PAM-clustering 
of 2 to 24 clusters. The clustering results were visually inspected, and validated in 
silhouette plots, and the best clustering (fewest outliers, high average silhouette 
value for all clusters) was seen when our annotated enhancers were divided to 16 
clusters. These are clusters 2 to 17, clusters 0-1 being excluded from the clustering 
(as invariable regions cannot be clustered). Cluster 1 has high signal in all the TFs 
and CTCF, and cluster 0 has no signal in any of the TFs or CTCF.  To visualize the 
PAM-clusters, they were plotted along mean Mediator coordinate, so that cluster 2 
has the highest mean Mediator signal, and cluster 17 the lowest. In the visualization 
all read counts higher than 15 reads within the region are shown as signal "15 
reads". All the reads are down-sampled to the KLF signal, input-subtracted, KLF-
background 13 reads subtracted. The histone marker coverages are counted by 
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adding +/-500 bases overhang to the peaks before counting the coverage. 
Sonication INPUT is subtracted using the same +/- 500 bases overhang, otherwise 
histone coverages normalized as above. Data are not row-normalized, but show the 
raw signal.  
Motif Analysis and Heatmaps 
Transcription factor binding sites in enhancer and promoter elements were identified 
using HOMER software37, and were further analysed by PAM-clustering using library 
"cluster" in R36.  
 
Motif analysis was done with HOMER code annotate Peaks.pl, by using 1) peak 
widths as they were given in the peak call file, 2) +/400 bases 3) +/- 200 bases, and 
4) +/- 100 bases from the peak center. The results were inspected, and used to 
validate the PAM clustering analysis. To validate the enrichment of erythroid 
transcription factor motifs in super-enhancers, the findMotifs.pl tool from the HOMER 
suite was used with a peak width of +/-200bp from the center of constituent peaks 
within super enhancers. P-values correspond to corrected p in the HOMER output. 
Heatmaps were produced using HOMER, version 4.7. The heatmaps were 
visualized in R, using library heatmap.2 and RcolorBrewer.   
Analysis of Enhancer Elements in Transient Assays   
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Chick reporter construct cloning: Enhancer regions were amplified from mouse 
genomic DNA using KAPA HiFi polymerase and primers described in the table 
below. Gel purified amplicons were cloned using a Golden gate assembly 
approach37 into a novel Citrine (YFP variant) reporter vector containing BsmBI-
flanked LacZ expression cassette upstream of the mouse minimal alpha globin 
promoter (HB2) and Citrine fluorescent protein ORF. Negative control constructs 
were made by inserting a short negative region instead of an enhancer. The negative 
region was assembled by annealing two oligonucleotides. Endotoxin-free maxi preps 
were prepared for in vivo electroporation using Qiagen’s kit (12362).  
 
Primers for construct generation: R1Fwd, 
TTTTTTCGTCTCgccagggcatcgagtggagagaaggg; R1Rev, 
TTTTTTCGTCTCcaacagtcgagtttatgctgcgtcct;  R2Fwd, 
TTTTTTCGTCTCgccaggtttgctaaacatctgtcaggga; R2Rev, 
TTTTTTCGTCTCcaacagcgagaagtctgcccaggttt; R3Fwd, 
TTTTTTCGTCTCgccagggcccttcccctgaacactta; R3Rev, 
TTTTTTCGTCTCcaacagtagcctgtctcccttccctc; R4Fwd, 
TTTTTTCGTCTCgccagggccataccttccgactctga; R4Rev 
TTTTTTCGTCTCcaacagtcaacttccgacccagtgtg; R(m)Fwd, 
TTTTTTCGTCTCgccagggacacagtaaatcccaagcca; R(m)Rev, 
TTTTTTCGTCTCcaacagccacatggtaagatcctgtc; NegFwd, 
ccaggAGCTGGATCGATgatatcCGATCGATCGTAGCAC; NegRev, 
aacagGTGCTACGATCGATCGgatatcATCGATCCAGCT. 
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Individual reporter constructs together with control construct, ubiquitously expressing 
histone2B-tethered RFP, were co-electroporated into the entire epiblast of the early 
chick gastrula embryos (Hamburger-Hamilton stage 4, HH4), as previously 
described39. Following electroporation, embryos were allowed to develop to desired 
stages using ex-ovo culture in thin albumin, supplemented with 1% 
penicillin/streptomycin. Reporter reporter activity was monitored up to 3 days post 
electroporation using fluorescence microscopy.  
 
Enhancer activity was also assayed using an established mouse transgenic system 
where a vector containing a candidate enhancer, a minimal promoter, and the LacZ 
gene is stably integrated into the mouse genome via standard pronuclear 
injection17,18. The coordinates of enhancer elements assayed in this work are the 
same as those used for the chick enhancer assays. To visualize LacZ staining on 
histological sections, embryos were fixed in 4% paraformaldehyde at 4°C, washed 
three times in phosphate-buffered saline, embedded in OCT-compound (Sakura 
Finetek), and cut on a cryostat (Leica, Deerfiled, IL) at 10 µM. Specimens were 
viewed and photographed using a Nikon Eclipse E600 microscope and DXM1200C 
(Nikon) camera.  
 
Generation of knockout mouse models  
All mouse work was performed in accordance with UK Home Office regulations 
under approved project licences. Targeting and mouse model generation was 
performed as previously described14,19. A region of ~1kb encompassing the 
conserved sequence for each regulatory element (R1, R2, R3, Rm and R4, as 
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previously described16) was identified for deletion. The region was chosen to include 
all binding sites for erythroid specific transcription factor binding sites, without 
impinging on other active elements such as CTCF sites. The coding sequence of 
Nprl3 was preserved. Regions of homology totalling ~7kb were identified on either 
side of the planned deletion and were amplified from a mouse 129/Ola specific α-
globin bacterial artificial chromosome using a high fidelity Taq polymerase. These 
were cloned into the vector pGemT-easy for sequencing before excision with EcoR1, 
blunting with T4 polymerase, and ligation into the unique Srf1 and Bst1107I sites in 
the pNTFlox targeting vector. In this vector, the homology arms flank a floxed 
Neomycin resistance gene, driven by a PGK promoter. Outwith the homology arms, 
a herpes simplex thymidine kinase cassette, again driven by a PGK promoter, is 
included. Sequenced and purified vector was linearized at its unique XhoI site, and 
purified prior to electroporation into 129/Ola ES cells, which were then cultured in 
GMEM. Positive selection with G418 and negative selection with FIAU were used to 
isolate cells incorporating the construct. Correctly targeted clones were identified by 
Southern blotting, and were karyotyped prior to blastocyst injection and chimera 
generation.  
 
Following germline transmission, mice bearing the floxed neomycin resistance gene 
were crossed with GATA1-Cre expressing mice to excise the neomycin resistance 
cassette in all tissues40 as this has previously been shown to affect local gene 
expression41. This recombination leaves only a single residual loxP site and multiple 
cloning site footprint from the targeting vector. Southern blotting and sequencing 
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were used to confirm the correct deletion. Heterozygotes were then crossed to yield 
a line of mice homozygous for the single enhancer deletion. 
 
For double knockouts, targeted ES cell clones heterozygous for the floxed neomycin 
resistance cassette at the site of the first targeted enhancer were subject to in vitro 
cre recombination with pCAGGS-Cre. After loss of neomycin resistance and 
southern blotting to confirm the expected sequence, a further round of targeting was 
performed with pNTFLox bearing homology arms for the second enhancer to be 
deleted. Newly neomycin-resistant clones were then subject to a second 
recombination stage with a weaker cre-recombinase (MC-Cre), with the aim of 
achieving a discrete second enhancer deletion (avoiding a maximal deletion product 
which would employ the residual loxP from the preceding cre recombination involved 
in the deletion of the first enhancer). Southern blotting was used to identify clones in 
which the second enhancer had been targeted in cis, and deleted in isolation, 
maintaining the coding sequence of Nprl3. Correctly targeted clones were then 
karyotyped and injected into blastocysts to yield chimeras, with subsequent germline 
transmission. Coordinates of the five single knockouts im mm9 are: R1, 
chr11:32145028-32146147; R2, chr11:32150550-32151858; R3. chr11:32156048-
32157191; R(m), chr11:32165011-32165922; R4, chr11:32168783-32169689.  
Hematologic analysis of mouse models 
Hematologic phenotypes of a balanced mix of male and female mice for all models 
were examined at more than 7 weeks of age to avoid inter-individual variation42. All 
mice were generated on the same complex background. To compare the mouse 
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models we have pooled wild type samples from different pedigrees. Reticulocyte 
preparations were made using Brilliant Cresyl Blue staining, and counts were made 
by two independent assessors blinded to genotype. Sample sized were chosen with 
a view to detecting a 25% reduction in haemoglobin; smaller confirmatory datasets 
were obtained where the analysis of phenotype had already been reported (as for R2 
and R3 deletions14, 19. Data were subject to Levene’s test to confirm homogeneity of 
variance, followed by one-way ANOVA with Dunnett’s correction. 
 
Analysis of Steady State and Nascent RNA in Mouse Models   
Fetal livers were dissected from E12.5 mouse embryos and the dissociated cell 
suspension was expanded for 5-7 days in Stempro (Invitrogen) supplemented with 
Epo (1U/ml), SCF (50ng/ml) and dexamethasone (1µM). Following expansion of the 
cultures, mature red cells were removed by negative selection for Ter119 using anti-
Ter-119 magnetic beads (Miltenyi), to obtain a population of erythroid precursors. 
Cultures were then switched to medium containing high Epo (5U/ml) to induce 
differentiation to mature erythroid cells. Samples for total and nascent RNA were 
collected after 12 hours of differentiation. Cells were lysed in TriReagent (Sigma) 
and RNA was extracted according to the manufacturer’s instructions. Samples were 
DNase I treated using Turbo DNA-free (Ambion). To obtain nascent RNA, fetal liver 
cultures were pulsed with 50μM 4-thiouridine (Sigma) for 1 hour followed by 
immediate lysis in TriReagent. Nascent RNA was then extracted according to the 
method described by Dölken et al20. Quantification of total and nascent RNA 
transcripts was performed using NanoString nCounter technology, using a 
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customised probe set. Data were subject to Levene’s test to confirm homogeneity of 
variance, followed by one-way ANOVA with Dunnett’s correction.  
Analysis of Chromatin Landscape Using ATAC-seq.  
ATAC-Seq was performed on each mouse model as previously published33, using 
either cultured or uncultured fetal liver cells. 8-10x105 cells were used per biological 
replicate. For the double knockout models, fetal liver cells were cultured as 
described above. For the single knockout models, E14.5 fetal livers were 
disaggregated, filtered, stained with PE anti-mouse Ter119+ antibody (Ly-76, BD 
Pharmingen) and purified using MACS beads (Miltenyi Biotec) on a magnetic 
column. Cells were lysed and nuclei were isolated prior to transposition with Tn5 
transposase (Nextera, Illumina) for 30 minutes at 37°C. DNA was purified using a 
MinElute kit (Qiagen). Libraries were amplified and barcoded using the NEBNext 2x 
Mastermix (NEB) and the custom primers as previously described32. ATAC-Seq 
libraries profiles were visualized using D1000 tape on the Tapestation (Agilent) and 
quantified using a universal library quantification kit (KAPA Biosystems). Samples 
were sequenced using 75 cycles paired end kit on the NextSeq Illumina platform. 
Paired-end reads for ATAC-Seq were processed using our in-house customised 
DNase and CHIP pipeline: samples were aligned to the appropriate genome build 
(mm9) using bowtie (version 1.0.0)34. To prevent the exclusion of the duplicated 
globin genes bowtie was run with the –m reporting option set to 2 to allow reads to 
map twice to the genome. To exclude over- amplified products from these data sets, 
reads that map to the exact same genomic position were collapsed into a single 
representative read. Ploidy regions which represent regions in the genome which 
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strongly overreact in high-throughput sequencing experiments due to large copy 
number differences between the real genome and the genome build and normalize 
poorly were excluded at this stage from downstream analysis. For the mouse data 
we generated this set of regions in-house. Genome-wide tracks were produced using 
the in-house perl tool sam2bigwig.pl, which produces a track of read density over a 
set window size and increment of movement across the genome. Bowtie alignments 
were thus converted to genome wide density tracks (BigWig) and the output was 
displayed in UCSC Genome Browser43. Peak detection for ATAC-Seq was 
performed with the MACS2 algorithm44. Differential analysis between the double 
knockout R1-/-/R2-/- and WT was performed using the R package DiffBind.  
Analysis of Chromatin Landscape by NG Capture-C NG Capture-C was 
performed as described22. Cells were obtained using the fetal liver culture system 
outlined above. 3C libraries were made using standard methods similar to the 
protocol for in situ Hi-C.  Prior to oligonucleotide capture, 3C libraries were sonicated 
to 200 bp and Illumina paired-end sequencing adaptors (NEB E6040 / E7335 / 
E7500; Agilent Herculase II) were added.  Samples were indexed, allowing multiple 
samples to be pooled prior to oligonucleotide capture using biotinylated DNA 
oligonucleotides designed for the Hba-a1&2, Hbb-b1&2 and Slc25A37 promoters 
(Sigma). The first hybridisation reaction was scaled up relative to the number of 
samples included in the reaction to maintain library complexity (Nimblegen Roch 
SeqCap EZ). Following a 72h hybridisation step a streptavidin bead pull down 
(Invitrogen M270) was performed followed by multiple bead washes (Nimblegen 
SeqCap EZ) and PCR amplification of the captured material (Kappa / Nimblegen 
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SeqCap EZ accessory kit v2).  A single volume, double capture step was performed.  
The material was sequenced using the Illumina MiSeq with 150bp PE reads (300bp 
V2 chemistry). Data were analysed using analysis scripts (available via Github) and 
R was used to normalize data and generate differential tracks. 
 
Methods-only references 
33. Buenrostro, J.D., Giresi, P.G., Zaba, L.C., Chang, H.Y. & Greenleaf, W.J. 
Transposition of native chromatin for fast and sensitive epigenomic profiling of open 
chromatin, DNA-binding proteins and nucleosome position. Nat. Methods 10 1213–
1218 (2013). 
34. Langmead, B. Trapnell, C., Pop, M. & Salzberg, S.L. Ultrafast and memory-
efficient alignment of short DNA sequences to the human genome. Genome Biol. 10, 
R25 (2009). 
35. McGowan, S.J., Hughes, J.R., Han, Z.P. & Taylor, S. MIG: Multi-Image Genome 
viewer. Bioinformatics 29 2477–2478 (2013) 
36. Maechler, M., Rousseeuw, P., Struyf, A., Hubert, M. & Hornik, K. Cluster 
Analysis Basics and Extensions. R package version 2.0.3. (2015). 
 
37. Heinz, S. et al. Simple Combinations of Lineage-Determining Transcription 
Factors Prime cis-Regulatory Elements Required for Macrophage and B Cell 
Identities. Mol. Cell 38, 576–589 (2010) 
 
 
 45 
38. Engler, C., Gruetzner, R., Kandzia, R. & Mariollonnet, S. Golden gate shuffling: a 
one-pot DNA shuffling method based on type IIs restriction enzymes. PLoS One 4 
e5553 (2009). 
 
39. Sauka-Spengler, T. & Barembaum, M. Gain- and loss-of-function approaches in 
the chick embryo. Methods Cell .Biol. 87, 237–256 (2008). 
 
40. Mao, X., Fujiwara, Y. & Orkin, S.H. Improved reporter strain for monitoring Cre 
recombinase mediated DNA excisions in mice. Proc Natl Acad Sci USA 96 5037–
5042 (1999). 
 
41. Fiering, S. et al. Targeted deletion of 5’HS2 of the murine beta-globin LCR 
reveals that it is not essential for proper regulation of the beta-globin locus. Genes 
Dev. 15 2203–2213 (1995). 
 
42. Russell, E.S. & Berstein S.E. in Biology of the Laboratory Mouse 2nd edn (ed. 
Green, E.L.) Chapter 17 (Dover Publications Inc., New York, 1966). 
 
43. Kent, W.J. et al. The human genome browser at UCSC. Genome Res. 12 996–
1006 (2002). 
 
44. Feng, J., Liu, T., Qin, B., Zhang, Y. & Liu, X.S. Identifying ChIP-seq enrichment 
using MACS. Nat. Protoc. 7, 1728–1740 (2012). 
 
 46 
Statement of financial interest: 
The authors declare that they have no competing financial interests. 
   
